USP drug classification [BR:br08302] Antineoplastics Molecular Target Inhibitors Phosphatidylinositol-3-Kinase (PI3K) Inhibitors Inavolisib D11942 Inavolisib (USAN/INN) Drug groups [BR:br08330] Antineoplastic DG03139 PI3K inhibitor D11942 Inavolisib Target-based classification of drugs [BR:br08310] Enzymes Transferases (EC2) Phosphotransferase PIK3CA D11942 Inavolisib (USAN/INN) <US> New drug approvals in the USA [br08319.html] New molecular entities and new therapeutic biological products D11942 New drug approvals in Europe [br08329.html] European public assessment reports (EPAR) authorised medicine D11942 New drug approvals in the USA, Europe and Japan [br08328.html] Approval dates by FDA, EMA and PMDA D11942